Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

GUANGZHOU LBP MEDICINE SCIENCE & TECHNOLOGY CO., LTD.

(688393)
SummaryChartsNewsCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

Guangzhou Anbiping Medical Laboratory Co., Ltd. announced that it expects to receive CNY 20 million in funding from Guangzhou LBP Medicine Science & Technology Co., Ltd., Guangzhou Anbiping No. 1 Investment Partnership Enterprise (Limited Partnership), Guangzhou Anbiping No. 2 Investment Partnership Enterprise (Limited Partnership)

09/23/2021 EST

Guangzhou Anbiping Medical Laboratory Co., Ltd. announced that it will raise CNY 20 million in a equity round of funding on September 23, 2021. The transaction include participation from Guangzhou Anbiping No. 1 Investment Partnership Enterprise (Limited Partnership), Guangzhou Anbiping No. 2 Investment Partnership Enterprise (Limited Partnership) and returning investor Guangzhou LBP Medicine Science & Technology Co., Ltd. The transaction was approved by the board of directors in its 9th session of the company’s 3rd directorate. The company's registered capital will increase from CNY10 million to CNY 30 million. The investors will hold 5%, 15% and 80% stake respectively after the transaction with investment of CNY 4,500,000, CNY 1,500,000 and CNY 24,000,000 respectively.


© S&P Capital IQ 2021
All news about GUANGZHOU LBP MEDICINE SCIENCE & TECHNOLOGY CO., LTD.
2021Guangzhou LBP Medicine Science & Technology Co., Ltd. Reports Earnings Results for the ..
CI
2021Guangzhou Anbiping Medical Laboratory Co., Ltd. announced that it expects to receive CN..
CI
2021Guangzhou Lbp Medicine Science & Technology Co., Ltd. Reports Earnings Results for the ..
CI
2021GUANGZHOU LBP MEDICINE SCIENCE & TEC : 688393) added to Shanghai Stock Exchange Composite ..
CI
2021GUANGZHOU LBP MEDICINE SCIENCE & TEC : 688393) added to Shanghai Stock Exchange A Share In..
CI
2021Certain A Shares of LBP Medicine Science & Technology Co., Ltd are subject to a Lock-Up..
CI
2021Guangzhou LBP Medicine Science & Technology Co., Ltd. Reports Earnings Results for the ..
CI
2021Guangzhou Lbp Medicine Science & Technology Co., Ltd. Reports Earnings Results for the ..
CI
2021Guangzhou LBP Medicine Science & Technology Co., Ltd. Reports Earnings Results for the ..
CI
2020Guangzhou LBP Medicine Science & Technology Co., Ltd. Reports Earnings Results for the ..
CI
More news
Financials
Sales 2020 375 M 59,2 M 59,2 M
Net income 2020 84,7 M 13,4 M 13,4 M
Net cash 2020 846 M 133 M 133 M
P/E ratio 2020 33,9x
Yield 2020 0,76%
Capitalization 2 874 M 453 M 453 M
EV / Sales 2019 -
EV / Sales 2020 6,94x
Nbr of Employees -
Free-Float 37,0%
Chart GUANGZHOU LBP MEDICINE SCIENCE & TECHNOLOGY CO., LTD.
Duration : Period :
Guangzhou LBP Medicine Science & Technology Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Income Statement Evolution
Managers and Directors
Xiang Ting Cai Chairman & General Manager
Zhi Liao Yang Financial Director
Zhen Wu Peng Chairman-Supervisory Board
Xin Ru Jin Member-Supervisory Board & Administrative Manager
De Ying Qian Independent Director
Sector and Competitors